Group | Median (IQR) total VEGF(ng/ml) | Median (IQR) bioactive VEGF(ng/ml) | Median difference(95% CI) |
---|---|---|---|
*p<0.001 v ELF levels of bioactive VEGF. | |||
†p<0.05 v ELF levels of bioactive VEGF in at risk and normal subjects. | |||
Bioactive VEGF levels were lower in ARDS patients with detectable sVEGFR-1 in BAL fluid but there was no difference in total VEGF levels. | |||
Normal | 234.9* (160.6–359.2) | 6.52 (3.50–9.73) | 228.38 (158.6 to 349.6) |
At risk | 439.1* (322.7–550.2) | 5.01 (2.69–8.55) | 434.1 (317.8 to 562.7) |
ARDS | 163.7* (77.9–353.8) | 2.68† (0.82–5.90) | 161.02 (107.4 to 259.6) |